Practice guidelines for pancreatic cancer

Cancer Journal from Scientific American

Volumn 2, Issue 9999, 1996, Pages

  Goodnight, James ^a   Venook, Alan ^b   Fringer, Joanna ^c   Taylor, Cat ^d   Gilden, Ron ^e   Figlin, Robert A ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c IQ Solutions   (United States)

^d Preferred Oncol Networks of America   (United States)

^e CDP Services   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CANCER STAGING; CHILD; COST BENEFIT ANALYSIS; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PRACTICE GUIDELINE; PRESCHOOL CHILD; QUALITY OF LIFE; REVIEW;

AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; QUALITY OF LIFE;

EID: 0344742075     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Connolly MM, Dawson PJ, Michelassi F, et al. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 1987;206:366-373.
2. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-465.
3. American Cancer Society. Cancer Facts and Figures - 1995. Atlanta: American Cancer Society, 1995.
4. National Cancer Institute. Cancer of the Pancreas: Research Report. NIH Publication No. 92-2941. Bethesda, Maryland: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, August 1992.
5. Hirayama T. Epidemiology of pancreatic cancer in Japan. Jpn J Clin Oncol 76:49-60, 1989.
6. Howe GR. Jain M, Burch JD. Miller AB. Cigarette smoking and cancer of the pancreas: evidence from a population-based case-control study in Toronto, Canada. Int J Cancer 1991;47:323-328.
7. Gold EB. Gordis L. Diener MD. et al. Diet and other risk factors for cancer of the pancreas. Cancer 1985;55:460-467.
8. Kaiser MH, Barkin J, MacIntyre JM. Pancreatic cancer: assessment of prognosis by clinical presentation. Cancer 1985;56:397-402.
9. Balthazar EJ, Chako AC. Computed tomography of pancreatic masses. Am J Gastroenterol 1990;85:343-349.
10. Freeny PC. Radiology of the pancreas: two decades in imaging and intervention. Am J Roentgenol 1988;150:975-981
11. Cohn I Jr. Overview of pancreatic cancer, 1989. Int J Pancteatol 1990;7:1-11.
12. Tio TL, Tytgat GNJ, Cikot RJLM, Houthoff HJ, Sars PRA. Ampullopancreatic carcinoma: preoperative TNM classification with endosonography. Radiology 1990;175:455-461.
13. Hayashi Y, Nakazawa S, Kimoto E, Naito Y, Morita K. Clinico-pathologic analysis of endoscopie ultrasonograms in pancreatic mass lesions. Endoscopy 1989;21:121-125.
14. Kaufman AR, Sivak MV Jr. Endoscopic ultrasonography in the differential diagnosis of pancreatic disease. Gastrointest Endosc 1989;35:214-219.
15. Chang KJ, Albers CG, Erickson RA, Butler JA, Wuerker RB, Lin F. Endoscopic ultrasound-guided fine needle aspiration of pancreatic carcinoma. Am J Gastroenterol 1994;89:263-266.
16. Chang KJ, Katz KD, Durbin TE, et al. Endoscopic ultrasound guided fine needle aspiration. Gastrointest Endosc 1994;40:694-649.
17. Warshaw AE, Gu Z-Y, Wittenberg J, et al. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 1990;125:230-233.
18. Warshaw AL,. Tepper JE, Shipley WU, et al. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 1986;151:76-80.
19. Cuschieri A. Laparoscopy for pancreatic cancer does it benefit the patient? Eur J Surg Oncol 1988;14:41-41.
20. Hermanek P. Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 1991;17:167-172.
21. American Joint Committee on Cancer. Exocrine Cancer. In: American Joint Committee on Cancer: Manual for Staging of Cancer. 4th ed. Philadelphia: J.B. Eippincott, 1992:109-113.
22. Crist DW, Sitzmann JV, Cameron JE. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358-365.
23. Grace PA, Pitt HA, Tompkins RK, et al. Decreased morbidity and mortality after pancreaticoduodenectomy. Am J Surg 1986;151:141-148.
24. Trede M, Schwall G, Saeger HD. Survival after pancreaticoduodenectomy. Ann Surg 1990;211:447-458.
25. Pellegrini CA, Heck CF, Raper S, et al. An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy. Arch Surg 1989;124:778-781.
26. Cameron JE, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120-125.
27. Dalton RR, Sarr MG, van Heerden JA, et al. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery 1992;111:489-494.
28. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-2010.
29. Gastrointestinal Tumor Study Group. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
30. Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma; a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 1981;48:1705-1710.
31. Tepper JE, Noyes D, Krall JM, et al. Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505. Int J Radiat Oncol Biol Phys 1991;21:1145-1149.
32. Whittington R, Solin E, Mohiuddin M, et al. Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer 1984;54:1991-1998.
33. Moertel CG, Childs DA, Reitemeier RJ, et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865-867.
34. Van den Bosch RP, van de Schelling GP, Klinkenbiji JH, et al. Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg 1994;219:18-24.
35. O'Connell MJ. Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol 1985;3:1032-1039.
36. Cullinan SA, Moertel CG, Fleming TR, et al. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. JAMA 1985;253:2061-2067.
37. Brennan MF, Kinsella TJ, Friedman M. Cancer of the pancreas. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: J.B. Lippincott Co., 3rd ed. 1989: 800-835.
38. Jaksic T, Yaman M, Thorner P et al. A 20-year review of pediatric pancreatic tumors. J Pediatr Surg 27:1315-1317, 1992.
39. Christman K, Kelsen D, Niedzwiecki D et al. Progression of pain and psychosocial distress over time in patients with pancreas cancer [abstract]. Proc Am Soc Clin Oncol 1992;11:A1441.
40. Leonard RC, Cull A, Stewart ME et al. Chemotherapy for pancreatic cancer significantly prolongs survival and quality of life is unimpaired [abstract]. Br J Cancer 1992;65[suppl 16]:8.
41. Tattersall MH, Simes RJ, Lumley T et al. Improved quality of life with megestrol acetate for patients with advanced non-endocrine sensitive cancer: a placebo controlled randomized trial [abstract]. Proc Am Soc Clin Oncol 1994;13:A1497.
42. Ebert M, Friess H, Berger HG et al. Role of octreotide in the treatment of pancreatic cancer. Digestion 1994;55[suppl 1]:48-51.
43. Ballinger AB, McHugh M, Catnach SM et al. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994;35:467-470.
44. Ishikawa O, Ohigashi FI, Nakaizumi A et al. Surgical resection of potentially curable pancreatic cancer with improved preservation of endocrine function-further evaluation of intraoperative cytodiagnosis. Hepatogastroenterology 1993;40:443-447.
45. Tamura K, Kin S, Nagami H, Yano S et al. Heterotopic autotransplantation of the distal pancreas segment after total pancreatectomy for cancer of the head of the pancreas. Pancreas 1992;7: 664-671.
46. Pretre R, Huber O, Robert J et al. Results of surgical palliation for cancer of the head of the pancreas and periampullary region. Br J Surg 1992;79:795-798.
47. Alvarez C, Livingston EH, Ashley SW et al. Cost-benefit analysis of the work-up for pancreatic cancer. Am J Surg 1993;165:53-58.
48. Lee MJ, Dawson SF, Mueller PR et al. Palliation of malignant bile duct obstruction with metallic biliary endoprostfieses: technique, results, and complications. J Vasc Interv Radiol 1992;3:665-671.
49. Brandabur JJ, Kozarek RA, Ball TJ et al. Nonoperative versus operative treatment of obstructive jaundice in pancreatic cancer: cost and survival analysis. Am J Gastroenterol 1988;83:1132-1139.
50. Lea MS, Stahlgren LH. Is resection appropriate for adenocarcinoma of the pancreas? A cost-benefit analysis. Am J Surg 1987; 154:651-654.